A two pager of what you need to know of Sofosbuvir

A two pager of what you need to know of Sofosbuvir

Bangkok 11 August 2015

TREAT Asia just published an overview documentation on Sofosbuvir, the snapshot provides a brief summary of the medication, its regulatory approvals, treatment response data from early clinical trials and pricing information.

Click here to see the full document

/ News

Share the Post

Related Posts

Hepatitis C vaccine fails to prevent chronic infections
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Strategies to Secure Access to Generic HCV Medicines
Response from CEO, CHAI about the Quick Start program in November 2016
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Progress report on access to hepatitis C treatment, WHO March 2018
Community group taking actions to enable greater access for generic HCV treatment